Key result
Levosimendan significantly improved systolic and diastolic function in dogs with pacing-induced cardiomyopathy, increasing Mw from 54 to 98 mm Hg (p < 0.05).
Why the study?
Does levosimendan improve left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy?
Population
Conscious dogs chronically instrumented for measurement of aortic and LV pressure, +dP/dt, subendocardial…
Comparison
Levosimendan vs Baseline measurements before levosimendan…
Design
Preclinical
Follow-up
22 +/- 2 days (pacing duration)
Authors
Loading...
Should not change clinical practice; hypothesis-generating for levosimendan effects in cardiomyopathy.
Does levosimendan improve left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy?
p-value: p=< 0.05
Levosimendan produces positive inotropic and lusitropic effects without altering heart rate or myocardial oxygen consumption in a canine model of pacing-induced cardiomyopathy.
Pagel et al. (1997) studied Pacing-induced cardiomyopathy. Levosimendan vs. Baseline (pre-pacing) was evaluated on Left ventricular systolic and diastolic function (Mw, +dP/dt, tau, dL/dt, Kp) (p=< 0.05). Levosimendan significantly improved systolic and diastolic function in dogs with pacing-induced cardiomyopathy, increasing Mw from 54 to 98 mm Hg (p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: